Increased responsiveness of peripheral blood mononuclear cells to in vitro TLR 2, 4 and 7 ligand stimulation in chronic pain patients.

Glial activation via Toll-like receptor (TLR) signaling has been shown in animals to play an important role in the initiation and establishment of chronic pain. However, our ability to assess this central immune reactivity in clinical pain populations is currently lacking. Peripheral blood mononucle...

Full description

Bibliographic Details
Main Authors: Yuen H Kwok, Mark R Hutchinson, Melanie G Gentgall, Paul E Rolan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3429430?pdf=render
_version_ 1828866089034973184
author Yuen H Kwok
Mark R Hutchinson
Melanie G Gentgall
Paul E Rolan
author_facet Yuen H Kwok
Mark R Hutchinson
Melanie G Gentgall
Paul E Rolan
author_sort Yuen H Kwok
collection DOAJ
description Glial activation via Toll-like receptor (TLR) signaling has been shown in animals to play an important role in the initiation and establishment of chronic pain. However, our ability to assess this central immune reactivity in clinical pain populations is currently lacking. Peripheral blood mononuclear cells (PBMCs) are an accessible source of TLR expressing cells that may mirror similarities in TLR responsiveness of the central nervous system. The aim of this study was to characterize the IL-1β response to various TLR agonists in isolated PBMCs from chronic pain sufferers (on and not on opioids) and pain-free controls. Venous blood was collected from 11 chronic pain sufferers on opioids (≥ 20 mg of morphine / day), 8 chronic pain sufferers not on opioids and 11 pain-free controls. PBMCs were isolated and stimulated in vitro with a TLR2 (Pam3CSK4), TLR4 (LPS) or TLR7 (imiquimod) agonist. IL-1β released into the supernatant was measured with ELISA. Significantly increased IL-1β expression was found in PBMCs from chronic pain sufferers (on and not on opioids) compared with pain-free controls for TLR2 (F((6, 277)) = 15, P<0.0001), TLR4 (F((8, 263)) = 3, P = 0.002) and TLR7 (F((2,201)) = 5, P = 0.005) agonists. These data demonstrate that PBMCs from chronic pain sufferers were more responsive to TLR agonists compared with controls, suggesting peripheral cells may have the potential to become a source of biomarkers for chronic pain.
first_indexed 2024-12-13T04:43:07Z
format Article
id doaj.art-ac297bfff59247b4a8936f602a5fd398
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T04:43:07Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ac297bfff59247b4a8936f602a5fd3982022-12-21T23:59:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4423210.1371/journal.pone.0044232Increased responsiveness of peripheral blood mononuclear cells to in vitro TLR 2, 4 and 7 ligand stimulation in chronic pain patients.Yuen H KwokMark R HutchinsonMelanie G GentgallPaul E RolanGlial activation via Toll-like receptor (TLR) signaling has been shown in animals to play an important role in the initiation and establishment of chronic pain. However, our ability to assess this central immune reactivity in clinical pain populations is currently lacking. Peripheral blood mononuclear cells (PBMCs) are an accessible source of TLR expressing cells that may mirror similarities in TLR responsiveness of the central nervous system. The aim of this study was to characterize the IL-1β response to various TLR agonists in isolated PBMCs from chronic pain sufferers (on and not on opioids) and pain-free controls. Venous blood was collected from 11 chronic pain sufferers on opioids (≥ 20 mg of morphine / day), 8 chronic pain sufferers not on opioids and 11 pain-free controls. PBMCs were isolated and stimulated in vitro with a TLR2 (Pam3CSK4), TLR4 (LPS) or TLR7 (imiquimod) agonist. IL-1β released into the supernatant was measured with ELISA. Significantly increased IL-1β expression was found in PBMCs from chronic pain sufferers (on and not on opioids) compared with pain-free controls for TLR2 (F((6, 277)) = 15, P<0.0001), TLR4 (F((8, 263)) = 3, P = 0.002) and TLR7 (F((2,201)) = 5, P = 0.005) agonists. These data demonstrate that PBMCs from chronic pain sufferers were more responsive to TLR agonists compared with controls, suggesting peripheral cells may have the potential to become a source of biomarkers for chronic pain.http://europepmc.org/articles/PMC3429430?pdf=render
spellingShingle Yuen H Kwok
Mark R Hutchinson
Melanie G Gentgall
Paul E Rolan
Increased responsiveness of peripheral blood mononuclear cells to in vitro TLR 2, 4 and 7 ligand stimulation in chronic pain patients.
PLoS ONE
title Increased responsiveness of peripheral blood mononuclear cells to in vitro TLR 2, 4 and 7 ligand stimulation in chronic pain patients.
title_full Increased responsiveness of peripheral blood mononuclear cells to in vitro TLR 2, 4 and 7 ligand stimulation in chronic pain patients.
title_fullStr Increased responsiveness of peripheral blood mononuclear cells to in vitro TLR 2, 4 and 7 ligand stimulation in chronic pain patients.
title_full_unstemmed Increased responsiveness of peripheral blood mononuclear cells to in vitro TLR 2, 4 and 7 ligand stimulation in chronic pain patients.
title_short Increased responsiveness of peripheral blood mononuclear cells to in vitro TLR 2, 4 and 7 ligand stimulation in chronic pain patients.
title_sort increased responsiveness of peripheral blood mononuclear cells to in vitro tlr 2 4 and 7 ligand stimulation in chronic pain patients
url http://europepmc.org/articles/PMC3429430?pdf=render
work_keys_str_mv AT yuenhkwok increasedresponsivenessofperipheralbloodmononuclearcellstoinvitrotlr24and7ligandstimulationinchronicpainpatients
AT markrhutchinson increasedresponsivenessofperipheralbloodmononuclearcellstoinvitrotlr24and7ligandstimulationinchronicpainpatients
AT melanieggentgall increasedresponsivenessofperipheralbloodmononuclearcellstoinvitrotlr24and7ligandstimulationinchronicpainpatients
AT paulerolan increasedresponsivenessofperipheralbloodmononuclearcellstoinvitrotlr24and7ligandstimulationinchronicpainpatients